ID

40274

Beschreibung

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01612286

Link

https://clinicaltrials.gov/show/NCT01612286

Stichworte

Versionen (2)
  1. 17.01.19 17.01.19 -
  2. 27.03.20 27.03.20 - Sarah Riepenhausen
Rechteinhaber

Zhejiang Cancer Hospital

Hochgeladen am

27. März 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Nasopharyngeal Carcinoma NCT01612286

Englisch

Eligibility Nasopharyngeal Carcinoma NCT01612286

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
Beschreibung

metastatic NPC, recent radiotherapy of NPC, recent chemoradiotherapy of NPC

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2931822
UMLS CUI [1,2]
C0027627
UMLS CUI [2,1]
C0332185
UMLS CUI [2,2]
C1522449
UMLS CUI [2,3]
C2931822
UMLS CUI [3,1]
C0332185
UMLS CUI [3,2]
C0436307
UMLS CUI [3,3]
C2931822
have measurable lesions
Beschreibung

measurable disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
no dysfunction of the major organs
Beschreibung

absent dysfunction of major organs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0178784
UMLS CUI [1,3]
C0205164
UMLS CUI [1,4]
C3887504
can understand this study and give a signed informed consent certificates
Beschreibung

comprehension of study protocol, informed consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C2348563
UMLS CUI [2]
C0021430
without a history of allergic reaction to the biological agents
Beschreibung

medical history, absent allergic reagents to biological agents

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C1527304
UMLS CUI [1,3]
C0005515
UMLS CUI [1,4]
C0332197
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating women; women of child-bearing age without contraception
Beschreibung

pregnancy, breast-feeding, female of child-bearing age with absent contraception

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C1960468
UMLS CUI [3,2]
C0332197
UMLS CUI [3,3]
C0700589
with a serious infection or dysfunction of the major organs
Beschreibung

serious dysfunction of major organs, serious infection of major organs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0205404
UMLS CUI [1,2]
C3887504
UMLS CUI [1,3]
C0178784
UMLS CUI [1,4]
C0205164
UMLS CUI [2,1]
C0205404
UMLS CUI [2,2]
C3714514
UMLS CUI [2,3]
C0178784
UMLS CUI [2,4]
C0205164
have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
Beschreibung

recent other cancer treatment with pharmaceutical preparations

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0332185
UMLS CUI [1,4]
C0013227
allergic to the escherichia coli preparations
Beschreibung

hypersensitivity to Escherichia coli pharmaceutical preparations

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0014834
UMLS CUI [1,3]
C0013227
cann't understand this study and give a signed informed consent certificates
Beschreibung

absent comprehension of study protocol, absent informed consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C2348563
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0332197
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Nasopharyngeal Carcinoma NCT01612286

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
metastatic NPC, recent radiotherapy of NPC, recent chemoradiotherapy of NPC
Item
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
boolean
C2931822 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0332185 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C2931822 (UMLS CUI [2,3])
C0332185 (UMLS CUI [3,1])
C0436307 (UMLS CUI [3,2])
C2931822 (UMLS CUI [3,3])
measurable disease
Item
have measurable lesions
boolean
C1513041 (UMLS CUI [1])
absent dysfunction of major organs
Item
no dysfunction of the major organs
boolean
C0332197 (UMLS CUI [1,1])
C0178784 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
C3887504 (UMLS CUI [1,4])
comprehension of study protocol, informed consent
Item
can understand this study and give a signed informed consent certificates
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
medical history, absent allergic reagents to biological agents
Item
without a history of allergic reaction to the biological agents
boolean
C0262926 (UMLS CUI [1,1])
C1527304 (UMLS CUI [1,2])
C0005515 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
pregnancy, breast-feeding, female of child-bearing age with absent contraception
Item
pregnant or lactating women; women of child-bearing age without contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C1960468 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
serious dysfunction of major organs, serious infection of major organs
Item
with a serious infection or dysfunction of the major organs
boolean
C0205404 (UMLS CUI [1,1])
C3887504 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,4])
C0205404 (UMLS CUI [2,1])
C3714514 (UMLS CUI [2,2])
C0178784 (UMLS CUI [2,3])
C0205164 (UMLS CUI [2,4])
recent other cancer treatment with pharmaceutical preparations
Item
have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
boolean
C0920425 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0013227 (UMLS CUI [1,4])
hypersensitivity to Escherichia coli pharmaceutical preparations
Item
allergic to the escherichia coli preparations
boolean
C0020517 (UMLS CUI [1,1])
C0014834 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
absent comprehension of study protocol, absent informed consent
Item
cann't understand this study and give a signed informed consent certificates
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0021430 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video